Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 57,000 views, THTX YouTube video link below

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Sep 27, 2022 11:40am

68 Views

Post# 34989498

RE:RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link below

Good point - May the buyer always be aware as they possibly can to all the many ways various forces corrupt the free market system to their own advantage.

scarlet1967 wrote: So true also the ugliness could apply to the institutions look at Ed Nash's past roller coaster PTs and as per yourself recent trading by other institutions to make a quick profit. If you want to maximize your profit you need to use all avenues, a flexible multi purpose marketing approach others are doing it for a reason so why THTX almost certainly ignoring that part of the investment community?

SPCEO1 wrote: I really, really doubt TH had anything to do with this.

TH can get involved in the retail end of the investment sphere without getting involved in something like this. But no matter how you cut it, the retail end of the investment universe, now more than ever, is not pretty.

Despite how ugly that clip w as, the fact this caused the stock price to rise on decent volume is yet another indicator to TH that there is real hope for them to positively influence their share price by pursuing a retail strategy, particulalrly whent heir share price is too low, their market cap too low and their trading volume too low for institutional investors to participate in any meaningful way.

A higher share price always gives a company a better chance at economically building their business. For small biotech companies,it is one of the critical success factors.

qwerty22 wrote:
Either this character just randomly landed on THTX or THTX put themselves in front of him. Honestly the second option seems like the worst.

I don't see how this vid has anything to do with building their business

realitycheck4u wrote:

-- And what have we learned within this video?. We have learned that filtering out information to the retail channel helps build momentum.

SPCEO1 wrote: Just about everything this gentleman says about Trogarzo is embarrassingly wrong.

TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI